ID: ALA3334827

Max Phase: Preclinical

Molecular Formula: C21H23BrO3

Molecular Weight: 403.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C/C1=C\CC[C@@]2(C)O[C@@H]2[C@H]2OC(=O)/C(=C/c3ccccc3Br)[C@@H]2CC1

Standard InChI:  InChI=1S/C21H23BrO3/c1-13-6-5-11-21(2)19(25-21)18-15(10-9-13)16(20(23)24-18)12-14-7-3-4-8-17(14)22/h3-4,6-8,12,15,18-19H,5,9-11H2,1-2H3/b13-6+,16-12+/t15-,18-,19+,21+/m0/s1

Standard InChI Key:  KGKOCLWTNMKZIA-RSPRIGIOSA-N

Associated Targets(Human)

CCRF-CEM 65223 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HL-60(TB) 4309 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Oocyte 84 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 403.32Molecular Weight (Monoisotopic): 402.0831AlogP: 5.05#Rotatable Bonds: 1
Polar Surface Area: 38.83Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.44CX LogD: 5.44
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.29Np Likeness Score: 2.06

References

1. Penthala NR, Bommagani S, Janganati V, MacNicol KB, Cragle CE, Madadi NR, Hardy LL, MacNicol AM, Crooks PA..  (2014)  Heck products of parthenolide and melampomagnolide-B as anticancer modulators that modify cell cycle progression.,  85  [PMID:25117652] [10.1016/j.ejmech.2014.08.022]

Source